Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy

Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy

Messenger RNA (mRNA) vaccines offer an adaptable and scalable platform for cancer immunotherapy, requiring optimal design to elicit a robust and targeted immune response. Recent advancements in bioinformatics and artificial intelligence (AI) have significantly enhanced the design, prediction, and op...

Full description

Saved in:

Bibliographic Details
Main Authors:	Saber Imani, Xiaoyan Li, Keyi Chen, Mazaher Maghsoudloo, Parham Jabbarzadeh Kaboli, Mehrdad Hashemi, Saloomeh Khoushab, Xiaoping Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	neo-antigen mRNA vaccines lipid nanoparticles bioinformatics artificial intelligence targeted immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2024.1501010/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Neoantigen mRNA vaccines and A2A receptor antagonism: A strategy to enhance T cell immunity
by: Saber Imani, et al.
Published: (2025-12-01)

Editorial: Glycobiology and glycosylation: deciphering the secrets of glycans in humans and pathogens
by: Parham Jabbarzadeh Kaboli, et al.
Published: (2025-02-01)

Delivery of FGF18 using mRNA-LNP protects the cartilage against degeneration via alleviating chondrocyte senescence
by: Keyu Kong, et al.
Published: (2025-01-01)

CleanCap M6 inhibits decapping of exogenously delivered IVT mRNA
by: Zachary F. Mandell, et al.
Published: (2025-03-01)

Avian influenza mRNA vaccine encoding hemagglutinin provides complete protection against divergent H5N1 viruses in specific-pathogen-free chickens
by: Zhaoyang Wang, et al.
Published: (2025-01-01)

Identification of TTLL8, POTEE, and PKMYT1 as immunogenic cancer-associated antigens and potential immunotherapy targets in ovarian cancer
by: Esen Yonca Bassoy, et al.
Published: (2025-12-01)

Deciphering the role of miRNA-mRNA interactions in cerebral vasospasm post intracranial hemorrhage
by: Xiang Chu, et al.
Published: (2025-02-01)

Nuclear mRNA export
by: Chen Suli, et al.
Published: (2024-09-01)

Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics
by: Riccardo Rampado, et al.
Published: (2025-01-01)

Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
by: Amparo L. Figueroa, et al.
Published: (2025-12-01)

Immunogenicity of HIV-1 <i>Env</i> mRNA and <i>Env-Gag</i> VLP mRNA Vaccines in Mice
by: Qi Ma, et al.
Published: (2025-01-01)

Comprehensive bioinformatics analysis identifies hub genes associated with immune cell infiltration in early-onset schizophrenia
by: Shasha Wu, et al.
Published: (2025-01-01)

Targeting BCMA in multiple myeloma: designs, challenges, and future directions
by: Yi Hu, et al.
Published: (2025-02-01)

Current Advances and Future Prospects in Cancer Immunotherapeutics
by: Zeynep DEDE, et al.
Published: (2023-03-01)

Antigen Delivery Platforms for Next-Generation Coronavirus Vaccines
by: Aziz A. Chentoufi, et al.
Published: (2024-12-01)

CAR-T therapy for endocrine neoplasms: novel targets and combination of therapies
by: Fang Wang, et al.
Published: (2025-02-01)

Local delivery of TGF-β1-mRNA decreases fibrosis in osteochondral defects
by: Gianluca Fontana, et al.
Published: (2025-03-01)

Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice
by: Denis N. Kisakov, et al.
Published: (2025-01-01)

Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
by: Beatriz Ramos, et al.
Published: (2025-02-01)

Nonviral targeted mRNA delivery: principles, progresses, and challenges
by: Xi He, et al.
Published: (2025-01-01)

In vivo production of engineered ACE2 decoy protects lungs from SARS-CoV-2 infection
by: Yuta Suzuki, et al.
Published: (2025-03-01)

mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
by: A. A. Ilyichev, et al.
Published: (2020-12-01)

THE CHARACTERISTICS OF MIRNA BINDING SITES IN MRNA OF ZFHX3 GENE AND ITS ORTHOLOGS
by: A. М. Kondybayeva, et al.
Published: (2018-07-01)

Identification of robust and abundant reference transcripts for EV mRNA cargo normalization
by: Antje M. Zickler, et al.
Published: (2025-06-01)

Allergen immunotherapy in atopic dermatitis
by: Agnieszka Bogacz-Piaseczyńska, et al.
Published: (2024-08-01)

Estimation of translational importance of mammalian mRNA nucleotide sequence characteristics based on ribosome profiling data
by: O. A. Volkova, et al.
Published: (2017-02-01)

Mechanism of modified mRNA structure in COVID-19 vaccines for inducing neutralizing antibodies
by: Sabighoh Zanjabila, et al.
Published: (2024-10-01)

Editorial: Building public confidence in innovative mRNA vaccines
by: Jia Hu, et al.
Published: (2025-01-01)

A Spike-Based mRNA Vaccine Encapsulated in Phospholipid 1,2-Dioleoyl-sn-Glycero-3-PhosphoEthanolamine Containing Lipid Nanoparticles Induced Potent B- and T-Cell Responses Associated with Protection Against SARS-CoV-2 Infection and COVID-19-like Symptoms in Hamsters
by: Afshana Quadiri, et al.
Published: (2025-01-01)

mRNA-LNP vaccines combined with tPA signal sequence elicit strong protective immunity against Klebsiella pneumoniae
by: Ting Huang, et al.
Published: (2025-01-01)

Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
by: Wu Helena T., et al.
Published: (2025-01-01)

Comprehensive assessment of a miRNA-mRNA regulatory network in Meretrix meretrix: Implications for metabolism and autophagy across divergent growth rates
by: Yuchen Wang, et al.
Published: (2025-03-01)

DDO-adjuvanted influenza A virus nucleoprotein mRNA vaccine induces robust humoral and cellular type 1 immune responses and protects mice from challenge
by: Victoria Gnazzo, et al.
Published: (2025-02-01)

Immunotherapy in Recurrent Ovarian Cancer
by: Keyao Chen, et al.
Published: (2025-01-01)

The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)
by: Adewunmi Akingbola, et al.
Published: (2025-12-01)

Current trends in peanut allergy immunotherapy: a review
by: Klementyna Łyżwa, et al.
Published: (2024-04-01)

Development and Evaluation of the Immunogenic Potential of an Unmodified Nucleoside mRNA Vaccine for Herpes Zoster
by: Shun Zhang, et al.
Published: (2025-01-01)

HisCoM-mimi: software for hierarchical structural component analysis for miRNA-mRNA integration model for binary phenotypes
by: Yongkang Kim, et al.
Published: (2019-03-01)

Germ granule-mediated mRNA storage and translational control
by: Hoang-Anh Pham-Bui, et al.
Published: (2025-12-01)

Potential and development of cellular vesicle vaccines in cancer immunotherapy
by: Wenxi Zhao, et al.
Published: (2025-01-01)